🌍·4h agodiscovery
Definium trial suggests LSD could help treat anxiety; “One patient meets God. The other gets itchy.”; and Compass funds psilocybin-assisted therapist training
Publisher
T
The Microdose | Substack
Global
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- The Microdose | Substack
- Region
- Global
- Scope
- discovery
- Published
- September 18, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: The Microdose | Substack
Scope: discovery
Related coverage
More related coverage
schaeffersresearch.com/3h ago
Biotech Options Buzz: UTHR, NMRA, EWTX
gasworld/4h ago
Emirates Biotech and partner launch UAE organic waste-to-biogas pilot
Barron's/4h ago
Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
connectmoney.com/4h ago